Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Sponsor
Ege University
Study ID
NCT07193823
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety
  • Cognitive Dysfunction
  • Depression
  • Fatigue
  • Fatigue in Multiple Sclerosis
  • Multiple Sclerosis
  • Multiple Sclerosis (MS) - Relapsing-remitting
  • Overactive Bladder
  • Sexual Disfunction

Eligibility Criteria

Sex
FEMALE
Age
25 Years - 50 Years
Healthy Volunteers
Not accepted

Study Details

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction. For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Key Dates

First listed
Sep 26, 2025
Start date
Jul 16, 2024
Status verified
Sep 2025
Primary completion
Oct 31, 2025
Completion
Nov 30, 2025

Study Design

Enrollment
140 participants (estimated)

Primary Outcome Measure

Prevalence of sexual dysfunction in female patients with multiple sclerosis [ Time Frame: At enrollment (Baseline, cross-sectional assessment) ]

Central Contacts

Find similar trials

Nationwide
Depression trialsMultiple sclerosis trialsPsychiatry trialsMental health trialsBehavioral health trialsNeurology trialsBrain disorders trialsAutoimmune disease trials

Related Studies